Sparsentan
4 December 2023
No Comments
Sparsentan (Filspari) is an endothelin and angiotensin II receptor antagonist indicated to reduce proteinuria
Issue: November / December 2023
Manufacture of Sterile Medicinal Products – meeting EU GMP Annex 1 requirements
4 December 2023
No Comments
Now that the EU GMP Annex 1 requirements related to the Manufacture of Sterile Medicinal Products are live, the expectations of auditors have changed. Implementing fit-for-purpose Contamination Control Strategies is a challenge for many manufacturers. Anna Cluet of Rephine sets out how to identify compliance gaps and offers suggestions as to how to resolve them.
Assuring quality of oligonucleotide APIs and DPs
1 December 2023
No Comments
The development of oligonucleotide therapeutics continues to accelerate with progress in oligonucleotide chemistry and adoption of delivery technologies. This article will discuss the necessary steps to execute to assure quality of your oligonucleotide APIs and DPs, and compliance with agency expectations.
YMC – Improved Oligo and Peptide Purification using next generation LC-phases
1 December 2023
No Comments
Molecules of the future with high demands on purity Therapeutic oligonucleotides and peptides
Peptide-based nanoparticles for extrahepatic delivery of therapeutic RNA
1 December 2023
No Comments
RNA therapeutics has evolved tremendously during the las two decades. Eighteen RNA medicines are now on the market, but major challenges still remain. These challenges include finding strategies to enable the use of RNA therapeutics outside the liver in a safe and efficacious manner. This overview summarises the advances that industrial peptide-based nanoparticles are making on their way to the clinic. Peptide-based platforms offer significant advantages to deliver RNA medicines extrahepatically, including liver avoidance, decreased immunotoxicity and enhanced endosomal release.
The importance of investments to tackle the future challenges
1 December 2023
No Comments
This year’s edition of CPhI has once again proven the excitement and vitality of the pharmaceutical industry. Among the most significant highlights, the recognition of Enrico Zodio as CEO of the year during the prestigious CPhI Pharma Awards has shed light on an exceptional leader. Furthermore, the spotlight on companies like PROCOS, committed to a constant pursuit of quality, technology, and human resources…